Bristol-Myers Squibb Co (WBO:BMYS) EPS (Basic) : €-2.83 (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Bristol-Myers Squibb Co EPS (Basic)?

Bristol-Myers Squibb Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was €-5.42. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.83.

Bristol-Myers Squibb Co's EPS (Diluted) for the three months ended in Mar. 2024 was €-5.42. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €-2.84.

Bristol-Myers Squibb Co's EPS without NRI for the three months ended in Mar. 2024 was €-4.05. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was 1.00.

During the past 12 months, Bristol-Myers Squibb Co's average EPS without NRIGrowth Rate was -86.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was 5.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 14.80% per year. During the past 10 years, the average EPS without NRI Growth Rate was 18.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Bristol-Myers Squibb Co's highest 3-Year average EPS without NRI Growth Rate was 36.10% per year. The lowest was -20.90% per year. And the median was 9.95% per year.

Bristol-Myers Squibb Co EPS (Basic) Historical Data

The historical data trend for Bristol-Myers Squibb Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co EPS (Basic) Chart

Bristol-Myers Squibb Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

1.82

-3.28

2.79

2.80

3.56

Bristol-Myers Squibb Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EPS (Basic)	Get a 7-Day Free Trial															1.01	0.91	0.88	0.80	-5.42

Bristol-Myers Squibb Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Bristol-Myers Squibb Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(7358.925	-	0)	/	2069.000
	=	3.56

Bristol-Myers Squibb Co's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-10958.12	-	0)	/	2023.000
	=	-5.42

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.83

Bristol-Myers Squibb Co (WBO:BMYS) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Bristol-Myers Squibb Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Bristol-Myers Squibb Co (WBO:BMYS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (WBO:BMYS) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru BMY:Mexico 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BMYB34:Brazil BMY:Argentina

Address

430 East 29th Street, 14th Floor, New York, NY, USA, 10016

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

Bristol-Myers Squibb Co (WBO:BMYS) Headlines

No Headlines